{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:47:23Z","timestamp":1793310443214,"version":"4.5.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,10,22]],"date-time":"2017-10-22T00:00:00Z","timestamp":1508630400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00018-017-2685-8","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T19:13:01Z","timestamp":1508785981000},"page":"1057-1070","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["WNT signaling, the development of the sympathoadrenal\u2013paraganglionic system and neuroblastoma"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8183-9486","authenticated-orcid":false,"given":"J\u00fcrgen","family":"Becker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-2296","authenticated-orcid":false,"given":"J\u00f6rg","family":"Wilting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,22]]},"reference":[{"issue":"9\u201310","key":"2685_CR1","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/0284186X.2016.1195509","volume":"55","author":"P Kaatsch","year":"2016","unstructured":"Kaatsch P, Strothotte J, Becker C, Bielack S, Dirksen U, Blettner M (2016) Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival. Acta Oncol 55(9\u201310):1145\u20131151","journal-title":"Acta Oncol"},{"issue":"3","key":"2685_CR2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrc1014","volume":"3","author":"GM Brodeur","year":"2003","unstructured":"Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203\u2013216","journal-title":"Nat Rev Cancer"},{"issue":"23","key":"2685_CR3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris JM (2010) Recent advances in neuroblastoma. N Engl J Med 362(23):2202\u20132211","journal-title":"N Engl J Med"},{"issue":"9579","key":"2685_CR4","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369(9579):2106\u20132120","journal-title":"Lancet"},{"issue":"2","key":"2685_CR5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2008.16.6785","volume":"27","author":"SL Cohn","year":"2009","unstructured":"Cohn SL, Pearson AD, London WB, Monclair T, Ambros PF, Brodeur GM et al (2009) The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report. J Clin Oncol 27(2):289\u2013297","journal-title":"J Clin Oncol"},{"issue":"2","key":"2685_CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jnci\/73.2.405","volume":"73","author":"H Shimada","year":"1984","unstructured":"Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T et al (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73(2):405\u2013416","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"2685_CR7","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.1993.11.8.1466","volume":"11","author":"GM Brodeur","year":"1993","unstructured":"Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP et al (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11(8):1466\u20131477","journal-title":"J Clin Oncol"},{"issue":"12","key":"2685_CR8","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1200\/JCO.1988.6.12.1874","volume":"6","author":"GM Brodeur","year":"1988","unstructured":"Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D\u2019Angio G et al (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6(12):1874\u20131881","journal-title":"J Clin Oncol"},{"issue":"2","key":"2685_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K et al (2009) The International Neuroblastoma Risk Group (INRG) Staging System: an INRG Task Force Report. J Clin Oncol 27(2):298\u2013303","journal-title":"J Clin Oncol"},{"issue":"11","key":"2685_CR10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.ejca.2012.01.010","volume":"48","author":"T Iehara","year":"2012","unstructured":"Iehara T, Hiyama E, Tajiri T, Yoneda A, Hamazaki M, Fukuzawa M et al (2012) Is the prognosis of stage 4s neuroblastoma in patients 12\u00a0months of age and older really excellent? Eur J Cancer 48(11):1707\u20131712","journal-title":"Eur J Cancer"},{"issue":"9","key":"2685_CR11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1200\/JCO.2007.12.3349","volume":"26","author":"B Hero","year":"2008","unstructured":"Hero B, Simon T, Spitz R, Ernestus K, Gnekow AK, Scheel-Walter HG et al (2008) Localized infant neuroblastomas often show spontaneous regression: results of the prospective trials NB95-S and NB97. J Clin Oncol 26(9):1504\u20131510","journal-title":"J Clin Oncol"},{"key":"2685_CR12","volume-title":"Taschenlehrbuch der gesamten Anatomie Bd. 3 Histologie, Zytologie und Mikroanatomie des Menschen","author":"H Leonhardt","year":"1985","unstructured":"Leonhardt H (1985) Taschenlehrbuch der gesamten Anatomie Bd. 3 Histologie, Zytologie und Mikroanatomie des Menschen. Thieme, Stuttgart"},{"issue":"6\u20137","key":"2685_CR13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s11064-005-6966-5","volume":"30","author":"K Unsicker","year":"2005","unstructured":"Unsicker K, Huber K, Schutz G, Kalcheim C (2005) The chromaffin cell and its development. Neurochem Res 30(6\u20137):921\u2013925","journal-title":"Neurochem Res"},{"issue":"2","key":"2685_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3835(02)00199-4","volume":"184","author":"F Westermann","year":"2002","unstructured":"Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184(2):127\u2013147","journal-title":"Cancer Lett"},{"key":"2685_CR15","first-page":"1089","volume":"43","author":"JB Beckwith","year":"1963","unstructured":"Beckwith JB, Perrin EV (1963) In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am J Pathol 43:1089\u20131104","journal-title":"Am J Pathol"},{"issue":"1","key":"2685_CR16","first-page":"219","volume":"49","author":"V Ciccarone","year":"1989","unstructured":"Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res 49(1):219\u2013225","journal-title":"Cancer Res"},{"issue":"2","key":"2685_CR17","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1535-7163.MCT-13-0560-T","volume":"13","author":"DJ Duffy","year":"2014","unstructured":"Duffy DJ, Krstic A, Schwarzl T, Higgins DG, Kolch W (2014) GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling. Mol Cancer Ther 13(2):454\u2013467","journal-title":"Mol Cancer Ther"},{"key":"2685_CR18","first-page":"233","volume":"146","author":"A Nakagawara","year":"2004","unstructured":"Nakagawara A (2004) Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 146:233\u2013242","journal-title":"Prog Brain Res"},{"issue":"8","key":"2685_CR19","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/onc.2012.106","volume":"32","author":"JH Schulte","year":"2013","unstructured":"Schulte JH, Lindner S, Bohrer A, Maurer J, De Preter K, Lefever S et al (2013) MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Oncogene 32(8):1059\u20131065","journal-title":"Oncogene"},{"issue":"3","key":"2685_CR20","first-page":"484","volume":"128","author":"M Tsokos","year":"1987","unstructured":"Tsokos M, Scarpa S, Ross RA, Triche TJ (1987) Differentiation of human neuroblastoma recapitulates neural crest development. Study of morphology, neurotransmitter enzymes, and extracellular matrix proteins. Am J Pathol 128(3):484\u2013496","journal-title":"Am J Pathol"},{"key":"2685_CR21","first-page":"766","volume-title":"Anatomie","author":"W Kummer","year":"2010","unstructured":"Kummer W (2010) Vegetatives nervensystem. In: Zilles KT (ed) Anatomie. Springer Medizin Verlag Heidelberg, Heidelberg, pp 766\u2013776"},{"issue":"2","key":"2685_CR22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1748-1716.2007.01811.x","volume":"192","author":"L Diaz-Flores","year":"2008","unstructured":"Diaz-Flores L, Gutierrez R, Varela H, Valladares F, Alvarez-Arguelles H, Borges R (2008) Histogenesis and morphofunctional characteristics of chromaffin cells. Acta Physiol (Oxf) 192(2):145\u2013163","journal-title":"Acta Physiol (Oxf)"},{"issue":"3","key":"2685_CR23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF00217246","volume":"236","author":"T Iwanaga","year":"1984","unstructured":"Iwanaga T, Fujita T (1984) Sustentacular cells in the fetal human adrenal medulla are immunoreactive with antibodies to brain S-100 protein. Cell Tissue Res 236(3):733\u2013735","journal-title":"Cell Tissue Res"},{"issue":"2","key":"2685_CR24","first-page":"1P","volume":"118","author":"TP O\u2019Hea","year":"1952","unstructured":"O\u2019Hea TP (1952) Ganglion cells in the adrenal medulla. J Physiol 118(2):1P\u20132P","journal-title":"J Physiol"},{"issue":"10","key":"2685_CR25","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2559.1986.tb02539.x","volume":"10","author":"HD Schroder","year":"1986","unstructured":"Schroder HD, Johannsen L (1986) Demonstration of S-100 protein in sustentacular cells of phaeochromocytomas and paragangliomas. Histopathology 10(10):1023\u20131033","journal-title":"Histopathology"},{"issue":"1","key":"2685_CR26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1523\/JNEUROSCI.06-01-00260.1986","volume":"6","author":"G Leblanc","year":"1986","unstructured":"Leblanc G, Landis S (1986) Development of choline acetyltransferase (CAT) in the sympathetic innervation of rat sweat glands. J Neurosci 6(1):260\u2013265","journal-title":"J Neurosci"},{"issue":"14","key":"2685_CR27","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJMoa012277","volume":"346","author":"FH Schilling","year":"2002","unstructured":"Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B et al (2002) Neuroblastoma screening at one year of age. N Engl J Med 346(14):1047\u20131053","journal-title":"N Engl J Med"},{"issue":"1","key":"2685_CR28","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0012-1606(74)90291-7","volume":"41","author":"NM Ledouarin","year":"1974","unstructured":"Ledouarin NM, Teillet MAM (1974) Experimental analysis of migration and differentiation of neuroblasts of autonomic nervous-system and of neurectodermal mesenchymal derivatives, using a biological cell marking technique. Dev Biol 41(1):162\u2013184","journal-title":"Dev Biol"},{"issue":"2","key":"2685_CR29","first-page":"355","volume":"145","author":"JC Weston","year":"1963","unstructured":"Weston JC (1963) Action of hydrocortisone on chick embryo. Anat Rec 145(2):355","journal-title":"Anat Rec"},{"issue":"2","key":"2685_CR30","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ydbio.2006.07.010","volume":"298","author":"K Huber","year":"2006","unstructured":"Huber K (2006) The sympathoadrenal cell lineage: specification, diversification, and new perspectives. Dev Biol. 298(2):335\u2013343","journal-title":"Dev Biol."},{"issue":"1","key":"2685_CR31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00441-014-1947-0","volume":"359","author":"K Huber","year":"2015","unstructured":"Huber K (2015) Segregation of neuronal and neuroendocrine differentiation in the sympathoadrenal lineage. Cell Tissue Res 359(1):333\u2013341","journal-title":"Cell Tissue Res"},{"issue":"1","key":"2685_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ydbio.2016.06.022","volume":"417","author":"E Maj","year":"2016","unstructured":"Maj E, Kunneke L, Loresch E, Grund A, Melchert J, Pieler T et al (2016) Controlled levels of canonical Wnt signaling are required for neural crest migration. Dev Biol. 417(1):77\u201390","journal-title":"Dev Biol."},{"issue":"2","key":"2685_CR33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/dgd.12189","volume":"57","author":"R Lumb","year":"2015","unstructured":"Lumb R, Schwarz Q (2015) Sympathoadrenal neural crest cells: the known, unknown and forgotten? Dev Growth Differ 57(2):146\u2013157","journal-title":"Dev Growth Differ"},{"issue":"2","key":"2685_CR34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/pcmr.12568","volume":"30","author":"L Vibert","year":"2017","unstructured":"Vibert L, Aquino G, Gehring I, Subkankulova T, Schilling TF, Rocco A et al (2017) An ongoing role for Wnt signaling in differentiating melanocytes in vivo. Pigment Cell Melanoma Res. 30(2):219\u2013232","journal-title":"Pigment Cell Melanoma Res."},{"issue":"24","key":"2685_CR35","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.1242\/dev.02662","volume":"133","author":"JC Kasemeier-Kulesa","year":"2006","unstructured":"Kasemeier-Kulesa JC, Bradley R, Pasquale EB, Lefcort F, Kulesa PM (2006) Eph\/ephrins and N-cadherin coordinate to control the pattern of sympathetic ganglia. Development 133(24):4839\u20134847","journal-title":"Development"},{"issue":"1","key":"2685_CR36","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ydbio.2006.12.028","volume":"304","author":"A Davy","year":"2007","unstructured":"Davy A, Soriano P (2007) Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development. Dev Biol 304(1):182\u2013193","journal-title":"Dev Biol"},{"issue":"8","key":"2685_CR37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0960-9822(06)00256-9","volume":"7","author":"CE Krull","year":"1997","unstructured":"Krull CE, Lansford R, Gale NW, Collazo A, Marcelle C, Yancopoulos GD et al (1997) Interactions of Eph-related receptors and ligands confer rostrocaudal pattern to trunk neural crest migration. Curr Biol 7(8):571\u2013580","journal-title":"Curr Biol"},{"issue":"4","key":"2685_CR38","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/(SICI)1097-0177(199904)214:4<312::AID-AJA4>3.0.CO;2-A","volume":"214","author":"RP Tucker","year":"1999","unstructured":"Tucker RP, Hagios C, Chiquet-Ehrismann R, Lawler J, Hall RJ, Erickson CA (1999) Thrombospondin-1 and neural crest cell migration. Dev Dynam 214(4):312\u2013322","journal-title":"Dev Dynam"},{"issue":"1","key":"2685_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0012-1606(90)90273-L","volume":"139","author":"KS Vogel","year":"1990","unstructured":"Vogel KS, Weston JA (1990) The sympathoadrenal lineage in avian embryos. 1. Adrenal chromaffin cells lose neuronal traits during embryogenesis. Dev Biol 139(1):1\u201312","journal-title":"Dev Biol"},{"issue":"2","key":"2685_CR40","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1073\/pnas.72.2.728","volume":"72","author":"NM Ledouarin","year":"1975","unstructured":"Ledouarin NM, Renaud D, Teillet MA, Ledouarin GH (1975) Cholinergic differentiation of presumptive adrenergic neuroblasts in interspecific chimeras after heterotopic transplantations. P Natl Acad Sci USA 72(2):728\u2013732","journal-title":"P Natl Acad Sci USA"},{"issue":"1","key":"2685_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dvdy.20919","volume":"236","author":"ML Harris","year":"2007","unstructured":"Harris ML, Erickson CA (2007) Lineage specification in neural crest cell pathfinding. Dev Dyn 236(1):1\u201319","journal-title":"Dev Dyn"},{"issue":"13","key":"2685_CR42","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1242\/dev.127.13.2811","volume":"127","author":"Y Wakamatsu","year":"2000","unstructured":"Wakamatsu Y, Maynard TM, Weston JA (2000) Fate determination of neural crest cells by NOTCH-mediated lateral inhibition and asymmetrical cell division during gangliogenesis. Development 127(13):2811\u20132821","journal-title":"Development"},{"issue":"2","key":"2685_CR43","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0006-8993(78)90260-3","volume":"152","author":"K Unsicker","year":"1978","unstructured":"Unsicker K, Tschechne B, Tschechne D (1978) Formation of cholinergic synapses on adrenal chromaffin cells in anterior eye chamber transplants. Brain Res 152(2):334\u2013340","journal-title":"Brain Res"},{"key":"2685_CR44","first-page":"59","volume":"122","author":"D Saito","year":"2005","unstructured":"Saito D, Takahashi Y (2005) Migratory behaviors of adrenomedulla-fated neural crest cells are instructed by the adrenocortical cells. Mech Dev 122:59","journal-title":"Mech Dev"},{"key":"2685_CR45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1749-8104-3-28","volume":"3","author":"K Huber","year":"2008","unstructured":"Huber K, Franke A, Bruehl B, Krispin S, Ernsberger U, Schober A et al (2008) Persistent expression of BMP-4 in embryonic chick adrenal cortical cells and its role in chromaffin cell development. Neural Dev 3:28","journal-title":"Neural Dev"},{"key":"2685_CR46","first-page":"378","volume-title":"Anatomie","author":"U Welsch","year":"2010","unstructured":"Welsch U (2010) Endokrine organe. In: Zilles KT (ed) Anatomie. Springer Medizin Verlag heidelberg, Heidelberg, pp 378\u2013391"},{"issue":"1","key":"2685_CR47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13(1):11\u201326","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2685_CR48","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","volume":"8","author":"A Klaus","year":"2008","unstructured":"Klaus A, Birchmeier W (2008) Wnt signalling and its impact on development and cancer. Nat Rev Cancer 8(5):387\u2013398","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2685_CR49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrm3470","volume":"13","author":"C Niehrs","year":"2012","unstructured":"Niehrs C (2012) The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol 13(12):767\u2013779","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"2685_CR50","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2016.10.039","volume":"167","author":"B Hu","year":"2016","unstructured":"Hu B, Wang Q, Wang YA, Hua S, Sauve CG, Ong D et al (2016) Epigenetic activation of WNT5A drives glioblastoma stem cell differentiation and invasive growth. Cell 167(5):1281\u20131295 (e18)","journal-title":"Cell"},{"issue":"3","key":"2685_CR51","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00018-015-2076-y","volume":"73","author":"K Kumawat","year":"2016","unstructured":"Kumawat K, Gosens R (2016) WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci 73(3):567\u2013587","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"2685_CR52","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pbio.0040115","volume":"4","author":"AJ Mikels","year":"2006","unstructured":"Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4(4):e115","journal-title":"PLoS Biol"},{"issue":"21","key":"2685_CR53","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1093\/hmg\/ddt277","volume":"22","author":"JD Gray","year":"2013","unstructured":"Gray JD, Kholmanskikh S, Castaldo BS, Hansler A, Chung H, Klotz B et al (2013) LRP6 exerts non-canonical effects on Wnt signaling during neural tube closure. Hum Mol Genet 22(21):4267\u20134281","journal-title":"Hum Mol Genet"},{"issue":"22","key":"2685_CR54","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1101\/gad.1957710","volume":"24","author":"L Grumolato","year":"2010","unstructured":"Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R et al (2010) Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev 24(22):2517\u20132530","journal-title":"Genes Dev"},{"issue":"57","key":"2685_CR55","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1038\/sj.onc.1210053","volume":"25","author":"AJ Mikels","year":"2006","unstructured":"Mikels AJ, Nusse R (2006) Wnts as ligands: processing, secretion and reception. Oncogene 25(57):7461\u20137468","journal-title":"Oncogene"},{"issue":"1","key":"2685_CR56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-3701-2-14","volume":"2","author":"Y Yang","year":"2012","unstructured":"Yang Y (2012) Wnt signaling in development and disease. Cell Biosci 2(1):14","journal-title":"Cell Biosci"},{"issue":"11","key":"2685_CR57","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","volume":"36","author":"T Zhan","year":"2017","unstructured":"Zhan T, Rindtorff N, Boutros M (2017) Wnt signaling in cancer. Oncogene 36(11):1461\u20131473","journal-title":"Oncogene"},{"issue":"12","key":"2685_CR58","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/emboj.2012.146","volume":"31","author":"R Nusse","year":"2012","unstructured":"Nusse R, Varmus H (2012) Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J 31(12):2670\u20132684","journal-title":"EMBO J"},{"issue":"7","key":"2685_CR59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","volume":"13","author":"M Kahn","year":"2014","unstructured":"Kahn M (2014) Can we safely target the WNT pathway? Nat Rev Drug Discov 13(7):513\u2013532","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2685_CR60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jmcb\/mjt053","volume":"6","author":"F L\u2019Episcopo","year":"2014","unstructured":"L\u2019Episcopo F, Tirolo C, Caniglia S, Testa N, Morale MC, Serapide MF et al (2014) Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection\/repair in Parkinson\u2019s disease. J Mol Cell Biol 6(1):13\u201326","journal-title":"J Mol Cell Biol"},{"key":"2685_CR61","first-page":"301575","volume":"2014","author":"W Wan","year":"2014","unstructured":"Wan W, Xia S, Kalionis B, Liu L, Li Y (2014) The role of Wnt signaling in the development of Alzheimer\u2019s disease: a potential therapeutic target? Biomed Res Int 2014:301575","journal-title":"Biomed Res Int"},{"issue":"22","key":"2685_CR62","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1007\/s00018-012-0991-8","volume":"69","author":"TJ Stuhlmiller","year":"2012","unstructured":"Stuhlmiller TJ, Garcia-Castro MI (2012) Current perspectives of the signaling pathways directing neural crest induction. Cell Mol Life Sci 69(22):3715\u20133737","journal-title":"Cell Mol Life Sci"},{"issue":"5160","key":"2685_CR63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1126\/science.7513443","volume":"264","author":"MA Nieto","year":"1994","unstructured":"Nieto MA, Sargent MG, Wilkinson DG, Cooke J (1994) Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science 264(5160):835\u2013839","journal-title":"Science"},{"issue":"24","key":"2685_CR64","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1242\/dev.125.24.5055","volume":"125","author":"JP Liu","year":"1998","unstructured":"Liu JP, Jessell TM (1998) A role for rhoB in the delamination of neural crest cells from the dorsal neural tube. Development 125(24):5055\u20135067","journal-title":"Development"},{"issue":"13","key":"2685_CR65","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1242\/dev.125.13.2403","volume":"125","author":"C LaBonne","year":"1998","unstructured":"LaBonne C, Bronner-Fraser M (1998) Neural crest induction in Xenopus: evidence for a two-signal model. Development 125(13):2403\u20132414","journal-title":"Development"},{"issue":"11","key":"2685_CR66","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1242\/dev.01857","volume":"132","author":"J Calisto De","year":"2005","unstructured":"De Calisto J, Araya C, Marchant L, Riaz CF, Mayor R (2005) Essential role of non-canonical Wnt signalling in neural crest migration. Development 132(11):2587\u20132597","journal-title":"Development"},{"issue":"1495","key":"2685_CR67","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1098\/rstb.2007.2252","volume":"363","author":"S Kuriyama","year":"2008","unstructured":"Kuriyama S, Mayor R (2008) Molecular analysis of neural crest migration. Philos Trans R Soc Lond B Biol Sci 363(1495):1349\u20131362","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5350","key":"2685_CR68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1126\/science.279.5350.509","volume":"279","author":"A Hall","year":"1998","unstructured":"Hall A (1998) Rho GTPases and the actin cytoskeleton. Science 279(5350):509\u2013514","journal-title":"Science"},{"issue":"14","key":"2685_CR69","doi-asserted-by":"crossref","first-page":"6019","DOI":"10.1523\/JNEUROSCI.22-14-06019.2002","volume":"22","author":"WM Jurney","year":"2002","unstructured":"Jurney WM, Gallo G, Letourneau PC, McLoon SC (2002) Rac1-mediated endocytosis during ephrin-A2- and semaphorin 3A-induced growth cone collapse. J Neurosci 22(14):6019\u20136028","journal-title":"J Neurosci"},{"key":"2685_CR70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semcdb.2016.01.031","volume":"55","author":"A Shellard","year":"2016","unstructured":"Shellard A, Mayor R (2016) Chemotaxis during neural crest migration. Semin Cell Dev Biol 55:111\u2013118","journal-title":"Semin Cell Dev Biol"},{"issue":"2","key":"2685_CR71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ydbio.2004.09.034","volume":"277","author":"MJ Howard","year":"2005","unstructured":"Howard MJ (2005) Mechanisms and perspectives on differentiation of autonomic neurons. Dev Biol 277(2):271\u2013286","journal-title":"Dev Biol"},{"issue":"7","key":"2685_CR72","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1523\/JNEUROSCI.4243-10.2011","volume":"31","author":"A Armstrong","year":"2011","unstructured":"Armstrong A, Ryu YK, Chieco D, Kuruvilla R (2011) Frizzled3 is required for neurogenesis and target innervation during sympathetic nervous system development. J Neurosci 31(7):2371\u20132381","journal-title":"J Neurosci"},{"issue":"16","key":"2685_CR73","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/sj.onc.1203518","volume":"19","author":"A Eggert","year":"2000","unstructured":"Eggert A, Ikegaki N, Liu X, Chou TT, Lee VM, Trojanowski JQ et al (2000) Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19(16):2043\u20132051","journal-title":"Oncogene"},{"issue":"4","key":"2685_CR74","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1055\/s-2000-9677","volume":"212","author":"A Eggert","year":"2000","unstructured":"Eggert A, Ikegaki N, Liu XG, Brodeur GM (2000) Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma. Klin Padiatr 212(4):200\u2013205","journal-title":"Klin Padiatr"},{"issue":"23","key":"2685_CR75","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1523\/JNEUROSCI.1445-09.2009","volume":"29","author":"D Bodmer","year":"2009","unstructured":"Bodmer D, Levine-Wilkinson S, Richmond A, Hirsh S, Kuruvilla R (2009) Wnt5a mediates nerve growth factor-dependent axonal branching and growth in developing sympathetic neurons. J Neurosci 29(23):7569\u20137581","journal-title":"J Neurosci"},{"issue":"19","key":"2685_CR76","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1523\/JNEUROSCI.16-19-06208.1996","volume":"16","author":"AM Fagan","year":"1996","unstructured":"Fagan AM, Zhang H, Landis S, Smeyne RJ, Silos-Santiago I, Barbacid M (1996) TrkA, but not TrkC, receptors are essential for survival of sympathetic neurons in vivo. J Neurosci 16(19):6208\u20136218","journal-title":"J Neurosci"},{"issue":"2","key":"2685_CR77","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/dbio.1999.9269","volume":"210","author":"N Francis","year":"1999","unstructured":"Francis N, Farinas I, Brennan C, Rivas-Plata K, Backus C, Reichardt L et al (1999) NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev Biol 210(2):411\u2013427","journal-title":"Dev Biol"},{"key":"2685_CR78","doi-asserted-by":"crossref","first-page":"42523","DOI":"10.1038\/srep42523","volume":"7","author":"C Subashini","year":"2017","unstructured":"Subashini C, Dhanesh SB, Chen CM, Riya PA, Meera V, Divya TS et al (2017) Wnt5a is a crucial regulator of neurogenesis during cerebellum development. Sci Rep 7:42523","journal-title":"Sci Rep"},{"issue":"1","key":"2685_CR79","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ydbio.2013.02.013","volume":"377","author":"YK Ryu","year":"2013","unstructured":"Ryu YK, Collins SE, Ho HY, Zhao H, Kuruvilla R (2013) An autocrine Wnt5a-Ror signaling loop mediates sympathetic target innervation. Dev Biol 377(1):79\u201389","journal-title":"Dev Biol"},{"key":"2685_CR80","doi-asserted-by":"crossref","first-page":"a009175","DOI":"10.1101\/cshperspect.a009175","volume":"6","author":"J Green","year":"2014","unstructured":"Green J, Nusse R, van Amerongen R (2014) The role of Ryk and Ror receptor tyrosine kinases in Wnt signal transduction. Cold Spring Harb Perspect Biol 6:a009175","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"2685_CR81","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molbrainres.2004.09.003","volume":"132","author":"S Fan","year":"2004","unstructured":"Fan S, Ramirez SH, Garcia TM, Dewhurst S (2004) Dishevelled promotes neurite outgrowth in neuronal differentiating neuroblastoma 2A cells, via a DIX-domain dependent pathway. Brain Res Mol Brain Res 132(1):38\u201350","journal-title":"Brain Res Mol Brain Res"},{"issue":"3","key":"2685_CR82","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1044-7431(03)00229-X","volume":"24","author":"MH Orme","year":"2003","unstructured":"Orme MH, Giannini AL, Vivanco MD, Kypta RM (2003) Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells. Mol Cell Neurosci 24(3):673\u2013686","journal-title":"Mol Cell Neurosci"},{"issue":"7","key":"2685_CR83","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.onc.1208255","volume":"24","author":"E Blanc","year":"2005","unstructured":"Blanc E, Roux GL, Benard J, Raguenez G (2005) Low expression of Wnt-5a gene is associated with high-risk neuroblastoma. Oncogene 24(7):1277\u20131283","journal-title":"Oncogene"},{"key":"2685_CR84","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12885-016-2293-2","volume":"16","author":"C Dyberg","year":"2016","unstructured":"Dyberg C, Papachristou P, Haug BH, Lagercrantz H, Kogner P, Ringstedt T et al (2016) Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma. BMC Cancer 16:259","journal-title":"BMC Cancer"},{"issue":"37","key":"2685_CR85","doi-asserted-by":"crossref","first-page":"60310","DOI":"10.18632\/oncotarget.11203","volume":"7","author":"DJ Duffy","year":"2016","unstructured":"Duffy DJ, Krstic A, Schwarzl T, Halasz M, Iljin K, Fey D et al (2016) Wnt signalling is a bi-directional vulnerability of cancer cells. Oncotarget 7(37):60310\u201360331","journal-title":"Oncotarget"},{"issue":"10","key":"2685_CR86","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/sj.onc.1210769","volume":"27","author":"X Liu","year":"2008","unstructured":"Liu X, Mazanek P, Dam V, Wang Q, Zhao H, Guo R et al (2008) Deregulated Wnt\/beta-catenin program in high-risk neuroblastomas without MYCN amplification. Oncogene 27(10):1478\u20131488","journal-title":"Oncogene"},{"key":"2685_CR87","first-page":"21","volume-title":"Human Cell Culture. 1","author":"C Thiele","year":"1998","unstructured":"Thiele C (1998) Neuroblastoma Cell Lines. In: Masters J (ed) Human Cell Culture. 1. Lancaster, Kluwer Academic Publishers, pp 21\u201353"},{"issue":"12","key":"2685_CR88","doi-asserted-by":"crossref","first-page":"976","DOI":"10.18632\/oncotarget.410","volume":"2","author":"S Cantilena","year":"2011","unstructured":"Cantilena S, Pastorino F, Pezzolo A, Chayka O, Pistoia V, Ponzoni M et al (2011) Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas. Oncotarget 2(12):976\u2013983","journal-title":"Oncotarget"},{"issue":"23","key":"2685_CR89","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/onc.2009.80","volume":"28","author":"M Flahaut","year":"2009","unstructured":"Flahaut M, Meier R, Coulon A, Nardou KA, Niggli FK, Martinet D et al (2009) The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt\/beta-catenin pathway. Oncogene 28(23):2245\u20132256","journal-title":"Oncogene"},{"issue":"16","key":"2685_CR90","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199910143411601","volume":"341","author":"KK Matthay","year":"1999","unstructured":"Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK et al (1999) Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children\u2019s Cancer Group. N Engl J Med 341(16):1165\u20131173","journal-title":"N Engl J Med"},{"issue":"4","key":"2685_CR91","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2011.07.002","volume":"21","author":"I Ora","year":"2011","unstructured":"Ora I, Eggert A (2011) Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research. Semin Cancer Biol 21(4):217\u2013228","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"2685_CR92","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1002\/ijc.29077","volume":"135","author":"G Schleiermacher","year":"2014","unstructured":"Schleiermacher G, Janoueix-Lerosey I, Delattre O (2014) Recent insights into the biology of neuroblastoma. Int J Cancer 135(10):2249\u20132261","journal-title":"Int J Cancer"},{"issue":"1","key":"2685_CR93","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13073-017-0407-3","volume":"9","author":"DJ Duffy","year":"2017","unstructured":"Duffy DJ, Krstic A, Halasz M, Schwarzl T, Konietzny A, Iljin K et al (2017) Retinoic acid and TGF-beta signalling cooperate to overcome MYCN-induced retinoid resistance. Genome Med 9(1):15","journal-title":"Genome Med"},{"issue":"7","key":"2685_CR94","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14715\/cmb\/2017.63.7.2","volume":"63","author":"C Qi","year":"2017","unstructured":"Qi C, Zhang J, Chen X, Wan J, Wang J, Zhang P et al (2017) Hypoxia stimulates neural stem cell proliferation by increasing HIF-1\u03b1 expression and activating Wnt\/\u03b2-catenin signaling. Cell Mol Biol (Noisy-le-grand) 63(7):12\u201319","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"39","key":"2685_CR95","doi-asserted-by":"crossref","first-page":"16805","DOI":"10.1073\/pnas.0904606106","volume":"106","author":"A Pietras","year":"2009","unstructured":"Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjolund J, Gisselsson D et al (2009) HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA. 106(39):16805\u201316810","journal-title":"Proc Natl Acad Sci USA."},{"issue":"5","key":"2685_CR96","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccr.2006.08.026","volume":"10","author":"L Holmquist-Mengelbier","year":"2006","unstructured":"Holmquist-Mengelbier L, Fredlund E, Lofstedt T, Noguera R, Navarro S, Nilsson H et al (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10(5):413\u2013423","journal-title":"Cancer Cell"},{"key":"2685_CR97","doi-asserted-by":"crossref","first-page":"11158","DOI":"10.1038\/srep11158","volume":"5","author":"F Cimmino","year":"2015","unstructured":"Cimmino F, Pezone L, Avitabile M, Acierno G, Andolfo I, Capasso M et al (2015) Inhibition of hypoxia inducible factors combined with all-trans retinoic acid treatment enhances glial transdifferentiation of neuroblastoma cells. Sci Rep 5:11158","journal-title":"Sci Rep"},{"issue":"10","key":"2685_CR98","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1021\/acs.jproteome.6b00457","volume":"15","author":"F Cimmino","year":"2016","unstructured":"Cimmino F, Pezone L, Avitabile M, Persano L, Vitale M, Sassi M et al (2016) Proteomic alterations in response to hypoxia inducible factor 2alpha in normoxic neuroblastoma cells. J Proteome Res 15(10):3643\u20133655","journal-title":"J Proteome Res"},{"issue":"7","key":"2685_CR99","doi-asserted-by":"crossref","first-page":"e40976","DOI":"10.1371\/journal.pone.0040976","volume":"7","author":"H Ruffner","year":"2012","unstructured":"Ruffner H, Sprunger J, Charlat O, Leighton-Davies J, Grosshans B, Salathe A et al (2012) R-Spondin potentiates Wnt\/beta-catenin signaling through orphan receptors LGR4 and LGR5. PLoS One 7(7):e40976","journal-title":"PLoS One"},{"issue":"11","key":"2685_CR100","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1128\/MCB.00272-12","volume":"32","author":"KS Carmon","year":"2012","unstructured":"Carmon KS, Lin Q, Gong X, Thomas A, Liu Q (2012) LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt\/beta-catenin signaling. Mol Cell Biol 32(11):2054\u20132064","journal-title":"Mol Cell Biol"},{"issue":"10","key":"2685_CR101","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1593\/neo.11800","volume":"13","author":"A Coulon","year":"2011","unstructured":"Coulon A, Flahaut M, Muhlethaler-Mottet A, Meier R, Liberman J, Balmas-Bourloud K et al (2011) Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Neoplasia 13(10):991\u20131004","journal-title":"Neoplasia"},{"issue":"37","key":"2685_CR102","doi-asserted-by":"crossref","first-page":"40053","DOI":"10.18632\/oncotarget.5548","volume":"6","author":"GC Vieira","year":"2015","unstructured":"Vieira GC, Chockalingam S, Melegh Z, Greenhough A, Malik S, Szemes M et al (2015) LGR5 regulates pro-survival MEK\/ERK and proliferative Wnt\/beta-catenin signalling in neuroblastoma. Oncotarget 6(37):40053\u201340067","journal-title":"Oncotarget"},{"key":"2685_CR103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fcell.2015.00077","volume":"3","author":"H Forgham","year":"2015","unstructured":"Forgham H, Johnson D, Carter N, Veuger S, Carr-Wilkinson J (2015) Stem cell markers in neuroblastoma\u2014an emerging role for LGR5. Front Cell Dev Biol 3:77","journal-title":"Front Cell Dev Biol"},{"issue":"Pt 9","key":"2685_CR104","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1242\/jcs.123471","volume":"126","author":"C Deng","year":"2013","unstructured":"Deng C, Reddy P, Cheng Y, Luo CW, Hsiao CL, Hsueh AJ (2013) Multi-functional norrin is a ligand for the LGR4 receptor. J Cell Sci 126(Pt 9):2060\u20132068","journal-title":"J Cell Sci"},{"key":"2685_CR105","doi-asserted-by":"crossref","first-page":"170033","DOI":"10.1038\/sdata.2017.33","volume":"4","author":"JL Harenza","year":"2017","unstructured":"Harenza JL, Diamond MA, Adams RN, Song MM, Davidson HL, Hart LS et al (2017) Transcriptomic profiling of 39 commonly-used neuroblastoma cell lines. Sci Data 4:170033","journal-title":"Sci Data"},{"issue":"8","key":"2685_CR106","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/ng.3333","volume":"47","author":"TF Eleveld","year":"2015","unstructured":"Eleveld TF, Oldridge DA, Bernard V, Koster J, Daage LC, Diskin SJ et al (2015) Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet 47(8):864\u2013871","journal-title":"Nat Genet"},{"issue":"12","key":"2685_CR107","doi-asserted-by":"crossref","first-page":"e1006501","DOI":"10.1371\/journal.pgen.1006501","volume":"12","author":"OM Padovan-Merhar","year":"2016","unstructured":"Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM et al (2016) Enrichment of targetable mutations in the relapsed neuroblastoma genome. PLoS Genet 12(12):e1006501","journal-title":"PLoS Genet"},{"key":"2685_CR108","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/nar\/gks1082","volume":"41","author":"JL Huret","year":"2013","unstructured":"Huret JL, Ahmad M, Arsaban M, Bernheim A, Cigna J, Desangles F et al (2013) Atlas of genetics and cytogenetics in oncology and haematology in 2013. Nucleic Acids Res 41:920\u2013924","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2685_CR109","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.canlet.2007.06.011","volume":"256","author":"A Koppen","year":"2007","unstructured":"Koppen A, Ait-Aissa R, Hopman S, Koster J, Haneveld F, Versteeg R et al (2007) Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation. Cancer Lett 256(2):218\u2013228","journal-title":"Cancer Lett"},{"issue":"7","key":"2685_CR110","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/ijc.23180","volume":"122","author":"A Koppen","year":"2008","unstructured":"Koppen A, Ait-Aissa R, Koster J, Ora I, Bras J, van Sluis PG et al (2008) Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN. Int J Cancer 122(7):1455\u20131464","journal-title":"Int J Cancer"},{"issue":"11","key":"2685_CR111","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1002\/ijc.26295","volume":"130","author":"S Brouwer De","year":"2012","unstructured":"De Brouwer S, Mestdagh P, Lambertz I, Pattyn F, De Paepe A, Westermann F et al (2012) Dickkopf-3 is regulated by the MYCN-induced miR-17-92 cluster in neuroblastoma. Int J Cancer 130(11):2591\u20132598","journal-title":"Int J Cancer"},{"issue":"7","key":"2685_CR112","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/carcin\/bgr073","volume":"32","author":"BH Haug","year":"2011","unstructured":"Haug BH, Henriksen JR, Buechner J, Geerts D, Tomte E, Kogner P et al (2011) MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma. Carcinogenesis 32(7):1005\u20131012","journal-title":"Carcinogenesis"},{"issue":"2","key":"2685_CR113","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.canlet.2009.08.019","volume":"289","author":"I Revet","year":"2010","unstructured":"Revet I, Huizenga G, Koster J, Volckmann R, van Sluis P, Versteeg R et al (2010) MSX1 induces the Wnt pathway antagonist genes DKK1, DKK2, DKK3, and SFRP1 in neuroblastoma cells, but does not block Wnt3 and Wnt5A signalling to DVL3. Cancer Lett 289(2):195\u2013207","journal-title":"Cancer Lett"},{"issue":"29","key":"2685_CR114","doi-asserted-by":"crossref","first-page":"46187","DOI":"10.18632\/oncotarget.10070","volume":"7","author":"K Zins","year":"2016","unstructured":"Zins K, Schafer R, Paulus P, Dobler S, Fakhari N, Sioud M et al (2016) Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with beta-catenin-dependent and beta-catenin-independent signaling pathways. Oncotarget 7(29):46187\u201346202","journal-title":"Oncotarget"},{"issue":"7264","key":"2685_CR115","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nature08356","volume":"461","author":"SM Huang","year":"2009","unstructured":"Huang SM, Mishina YM, Liu S, Cheung A, Stegmeier F, Michaud GA et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461(7264):614\u2013620","journal-title":"Nature"},{"key":"2685_CR116","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1756-9966-32-100","volume":"32","author":"XH Tian","year":"2013","unstructured":"Tian XH, Hou WJ, Fang Y, Fan J, Tong H, Bai SL et al (2013) XAV939, a tankyrase 1 inhibitor, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt\/beta-catenin signaling pathway. J Exp Clin Cancer Res 32:100","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"2685_CR117","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/CAD.0000000000000478","volume":"28","author":"J Suebsoonthron","year":"2017","unstructured":"Suebsoonthron J, Jaroonwitchawan T, Yamabhai M, Noisa P (2017) Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells. Anticancer Drugs 28(5):469\u2013479","journal-title":"Anticancer Drugs"},{"issue":"1","key":"2685_CR118","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2010.06.028","volume":"48","author":"D Granchi","year":"2011","unstructured":"Granchi D, Corrias MV, Garaventa A, Baglio SR, Cangemi G, Carlini B et al (2011) Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levels. Bone 48(1):152\u2013159","journal-title":"Bone"},{"issue":"3","key":"2685_CR119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11060-010-0209-6","volume":"100","author":"A Bilir","year":"2010","unstructured":"Bilir A, Erguven M, Yazihan N, Aktas E, Oktem G, Sabanci A (2010) Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y. J Neurooncol 100(3):385\u2013395","journal-title":"J Neurooncol"},{"issue":"1\u20132","key":"2685_CR120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2014.02.011","volume":"348","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhou B, Liu Y, Chen K, Bao P, Wang Y et al (2014) Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt\/beta-catenin signaling in neuroblastoma. Cancer Lett 348(1\u20132):12\u201319","journal-title":"Cancer Lett"},{"issue":"9","key":"2685_CR121","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/cancers8090082","volume":"8","author":"B Lu","year":"2016","unstructured":"Lu B, Green BA, Farr JM, Lopes FC, Van Raay TJ (2016) WNT drug discovery: weaving through the screens, patents and clinical trials. Cancers (Basel) 8(9):E82","journal-title":"Cancers (Basel)"},{"issue":"41","key":"2685_CR122","doi-asserted-by":"crossref","first-page":"43182","DOI":"10.18632\/oncotarget.6568","volume":"6","author":"DJ Duffy","year":"2015","unstructured":"Duffy DJ, Krstic A, Halasz M, Schwarzl T, Fey D, Iljin K et al (2015) Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma. Oncotarget 6(41):43182\u201343201","journal-title":"Oncotarget"},{"issue":"1","key":"2685_CR123","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0940-9602(11)80337-7","volume":"174","author":"B Christ","year":"1992","unstructured":"Christ B, Wilting J (1992) From somites to vertebral column. Ann Anat 174(1):23\u201332","journal-title":"Ann Anat"},{"issue":"5","key":"2685_CR124","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-09-1936","volume":"16","author":"J Becker","year":"2010","unstructured":"Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R et al (2010) Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 16(5):1431\u20131441","journal-title":"Clin Cancer Res"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-017-2685-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-017-2685-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T02:06:31Z","timestamp":1659665191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-017-2685-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,22]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2685"],"URL":"https:\/\/doi.org\/10.1007\/s00018-017-2685-8","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,22]]}}}